| 1/8 | US=22 / Câncer Chau CH, Figg WD. Antiangiogenesis agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 527-36. |
| 2/8 | US=9 / Urologia Aragon-Ching JB, Dahut W. Investigational angiogenesis inhibitors. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 225-32. ISBN 978-1-60327-831-7. INIBIDORES DA ANGIOGENESE; ANTIANGIOGENESIS; ENSAIOS CLINICOS; CANCER DE PROSTATA; TIROSINA QUINASES |
| 3/8 | US=9 / Urologia Bocci G, Pasqualetti G, Di Paolo A, Crea F, Del Tacca M, Danesi R. Pharmacogenetics of angiogenesis. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 233-42. ISBN 978-1-60327-831-7. TERAPIA ANTIANGIOGENESIS; RISCO DE CANCER; POLIMORFISMOS DE NUCLEOTIDEO UNICO; HIF; MMP; TNF; VEGF |
| 4/8 | US=28 / Biol/Mol Grothey A. Antiangiogenesis agents in colorectal cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 371-84. ISBN 978-1-58829-870-6. |
| 5/8 | US=28 / Biol/Mol Burger RA. Antiangiogenesis therapies in gynecologic malignancies. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 441-56. ISBN 978-1-58829-870-6. QUIMIOTERAPIA; GLIOMA; GLIOBLASTOMA; ASTROCITOMA; MEDULOBLASTOMA; VASCULATURA |
| 6/8 | US=14 / Ginecologia DiSaia PJ. Tumors immunology, host defense mechanisms, and biologic therapy. In: DiSaia PJ, Creasman WT, editors. Clinical gynecologic oncology. 7th ed. Philadelphia: Mosby Elsevier, 2007. p. 593-636. ISBN 978-0-3230-3978-9. IMUNOLOGIA DE TUMORES; MECANISMOS DE DEFESA DO HOSPEDEIRO; TERAPIA BIOLOGICA; FATORES HUMORAIS; CELULAS NATURAL KILLER; IMUNIDADE HUMORAL; CITOCINAS; INTERFERONS; INTERLEUCINAS; FACTOR DE NECROSE TUMORAL; RETINOIDES; TERAPIA ANTIANGIOGENESIS |
| 7/8 | US=61 / Câncer Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE |
| 8/8 | US=16 / Tórax Onn A, Isobe T, Herbst RS. Novel therapeutic strategies: antiangiogenesis therapy in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 713-24. ISBN 0-7817-4620-5. INIBIDORES DA ANGIOGENESE; NEOPLASIA PULMONAR; AGENTES ANTI-VASCULARES; TERAPIA ANTI-VASCULAR |